CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹4,134 Cr | ₹3,238 Cr | ₹3,326 Cr | ₹3,755 Cr | ₹3,068 Cr |
What is the latest Cash Flow from Operating Activities ratio of CIPLA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹4,134 Cr |
Mar2023 | ₹3,238 Cr |
Mar2022 | ₹3,326 Cr |
Mar2021 | ₹3,755 Cr |
Mar2020 | ₹3,068 Cr |
How is Cash Flow from Operating Activities of CIPLA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹4,134 Cr | 27.68 | |
Mar2023 | ₹3,238 Cr | -2.65 | |
Mar2022 | ₹3,326 Cr | -11.43 | |
Mar2021 | ₹3,755 Cr | 22.38 | |
Mar2020 | ₹3,068 Cr | - |
Compare Cash Flow from Operating Activities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹123,327.7 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics | |
MANKIND PHARMA | ₹97,734.2 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.1% |
1.8% |
-1.6% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses